semaglutide shortage update FDA ends shortage, closing the door on compounded Wegovy, Ozempic RACGP - AJGP (Australian Journal

, - | 2023-03-09 09:24:34 , / / , ,

Ive been on it for a little over a year and now I have final stenosis and had to have a shoulder replacement done earlier this year now Im scheduled for back surgery next week

The reasons for stopping included side effects, cost, and difficulty sticking to the schedule of injections

The compounds are studied in cell culture and animal models, and any statement that moves from "studied in a model" to "helps with" a human condition is a claim the underlying evidence does not support

It is important to emphasize that GLP-1 receptor agonists are not approved by the FDA for endometriosis management, and there is no official indication for their use in this condition

The initial weeks may involve adjusting to the medication, with gradual changes in appetite and weight